Trial intelligence / Profile preview

Pilot RCT of aspirin for postpartum venous thromboembolism prophylaxis

2020-000619-58Phase 3Terminated

Sponsor
CHU Saint-Etienne
Start
Nov 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of aspirin in venous thromboembolism (VTE) (2 arms), sponsored by CHU Saint-Etienne. Primary endpoint: Subject recruitment rate per centre per month. Started Nov 2020; status: terminated.

02

Drugs

aspirin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on 2020-000619-58.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-000619-58.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call